Annual ROE
-32.43%
-8.99%-38.35%
December 31, 2023
Summary
- As of February 23, 2025, PCVX annual return on equity is -32.43%, with the most recent change of -8.99% (-38.35%) on December 31, 2023.
- During the last 3 years, PCVX annual ROE has fallen by -6.63% (-25.70%).
- PCVX annual ROE is now -163.49% below its all-time high of 51.08%, reached on December 31, 2018.
Performance
PCVX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-23.53%
+6.54%+21.75%
September 30, 2024
Summary
- As of February 23, 2025, PCVX quarterly return on equity is -23.53%, with the most recent change of +6.54% (+21.75%) on September 30, 2024.
- Over the past year, PCVX quarterly ROE has stayed the same.
- PCVX quarterly ROE is now -149.79% below its all-time high of 47.26%, reached on December 31, 2019.
Performance
PCVX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
PCVX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.4% | 0.0% |
| 3 y3 years | -25.7% | 0.0% |
| 5 y5 years | -163.5% | 0.0% |
PCVX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -38.4% | +8.0% | at high | +53.7% |
| 5 y | 5-year | -168.6% | +8.0% | -149.8% | +94.2% |
| alltime | all time | -163.5% | +8.0% | -149.8% | +94.2% |
Vaxcyte ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -23.53%(-21.7%) |
| Jun 2024 | - | -30.07%(+4.3%) |
| Mar 2024 | - | -28.83%(-10.0%) |
| Dec 2023 | -32.43%(+38.4%) | -32.04%(+26.6%) |
| Sep 2023 | - | -25.31%(-11.8%) |
| Jun 2023 | - | -28.69%(-23.2%) |
| Mar 2023 | - | -37.34%(-14.8%) |
| Dec 2022 | -23.44% | -43.84%(-13.8%) |
| Sep 2022 | - | -50.83%(+17.2%) |
| Jun 2022 | - | -43.37%(+16.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -37.22%(+14.7%) |
| Dec 2021 | -35.24%(+36.6%) | -32.44%(+13.9%) |
| Sep 2021 | - | -28.48%(+11.3%) |
| Jun 2021 | - | -25.60%(+9.1%) |
| Mar 2021 | - | -23.46%(-19.1%) |
| Dec 2020 | -25.80%(-154.6%) | -28.99%(-32.1%) |
| Sep 2020 | - | -42.68%(-19.6%) |
| Jun 2020 | - | -53.10%(-86.9%) |
| Mar 2020 | - | -405.05%(-957.1%) |
| Dec 2019 | 47.26%(-7.5%) | 47.26% |
| Dec 2018 | 51.08% | - |
FAQ
- What is Vaxcyte annual return on equity?
- What is the all time high annual ROE for Vaxcyte?
- What is Vaxcyte annual ROE year-on-year change?
- What is Vaxcyte quarterly return on equity?
- What is the all time high quarterly ROE for Vaxcyte?
- What is Vaxcyte quarterly ROE year-on-year change?
What is Vaxcyte annual return on equity?
The current annual ROE of PCVX is -32.43%
What is the all time high annual ROE for Vaxcyte?
Vaxcyte all-time high annual return on equity is 51.08%
What is Vaxcyte annual ROE year-on-year change?
Over the past year, PCVX annual return on equity has changed by -8.99% (-38.35%)
What is Vaxcyte quarterly return on equity?
The current quarterly ROE of PCVX is -23.53%
What is the all time high quarterly ROE for Vaxcyte?
Vaxcyte all-time high quarterly return on equity is 47.26%
What is Vaxcyte quarterly ROE year-on-year change?
Over the past year, PCVX quarterly return on equity has changed by 0.00% (0.00%)